Telik Inc (TELK) Return on Equity ROE from the first quarter 2018 to first quarter 2013 and annually, average high and low, overall ranking from Mar 31 2018 to Sep 30 2013 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Telik Inc  (TELK)

Telik Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Telik Inc in the first quarter 2018?
Telik Inc recorded a cumulative net loss of $-7 million during 12 months ending in the first quarter 2018, resulting in a negative return on equity (ROE) of -1384.39%.

Within the Biotechnology & Pharmaceuticals industry 53 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2014 from to 4500.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2018)
I. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Equity Change -65.82 % - -87.84 % - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -7 -5 -4 -5 3
Return On Equity (TTM) -1384.39 % -501.04 % -212.32 % -167.86 % 610.07 %
TELK's Total Ranking # 4500 # # # #
Equity (TTM) in Millions 1 -1 1 2 2
Seq. Equity Change - - -64.47 % -32.2 % -30.89 %
Seq. Net Income Change - - - - -

Back to TELK Management Effectiveness >> TELK's 5 Years Annual ROE >> Compare TELK ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 54
Sector # 442
Overall # 4500

Return On Equity Statistics
High Average Low
610.07 %
12.04 %
-501.04 %
(Sep 30 2013)   (Jun 30 2014)





TELK Annual Return On Equity (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2011)
2011

Total Equity in Millions 2 -9 8 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -5 -3 -12 0 0
Y / Y Net Income Change - - - - -
Return On Equity -316.01 % - -144.86 % - -

Back to TELK Management Effectiveness >> TELK's 5 Years Annual ROE >> Compare TELK ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
TELK's' Return on Equity at Yahoo Finance
TELK's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for TELK's Competitors
Subscribers only: Roe for Telik Inc's Suppliers
Subscribers only: Return On Equity for TELK's Customers




Companies with similar Return On Equity at Mar 31 2018, within Healthcare Sector ROE

Date modified: 2026-09-02T18:05:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.